Sold as Zovirax. Every FDA application for this active ingredient: 1 branded and 21 generic.
As of Nov 13, 2026, FDA lists 22 applications for Acyclovir Sodium (sold as Zovirax), first approved Oct 22, 1982, with 3 new uses approved and 0 published complete response letters.
| Product | Part | Spending, 2025 | Change | Beneficiaries |
|---|---|---|---|---|
| Acyclovir Sodium | Part D | $62K | +76% | 124 |
| Acyclovir Sodium | Part B | $18K | -36% | 131 |
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Oct 22, 1982 | ZoviraxNDA 18603 · TYPE 2/3 | Glaxosmithkline | 26 | Discontinued |
| Apr 22, 1997 | Acyclovir SodiumANDA 74596 | Chartwell Injectable | 1 | Discontinued |
| Apr 22, 1997 | Acyclovir SodiumANDA 74663 | Hospira | 5 | Discontinued |
| Apr 22, 1997 | Acyclovir SodiumANDA 74720 | Hospira | 12 | Discontinued |
| Apr 22, 1997 | Acyclovir SodiumANDA 74758 | Hospira | 5 | Discontinued |
| Aug 26, 1997 | Acyclovir SodiumANDA 74969 | Teva Parenteral | 4 | Discontinued |
| Oct 15, 1997 | Acyclovir SodiumANDA 74913 | Eurohlth Intl Sarl | 1 | Discontinued |
| Dec 10, 1997 | Acyclovir SodiumANDA 74897 | Apothecon | 0 | Discontinued |
| Dec 19, 1997 | Acyclovir In Sodium Chloride 0.9% Preservative FreeANDA 74885 | Eurohlth Intl Sarl | 1 | Discontinued |
| Apr 30, 1998 | Acyclovir SodiumANDA 75015 | Fresenius Kabi USA | 3 | Discontinued |
| May 13, 1998 | Acyclovir SodiumANDA 74930 | Fresenius Kabi USA | 4 | Marketed |
| Feb 25, 1999 | Acyclovir SodiumANDA 75065 | Hospira | 0 | Discontinued |
| Jul 26, 1999 | AcyclovirANDA 75114 | Abbvie | 0 | Discontinued |
| Mar 28, 2001 | Acyclovir SodiumANDA 75627 | Teva Parenteral | 0 | Discontinued |
| Oct 11, 2013 | Acyclovir SodiumANDA 203701 | Eugia Pharma | 0 | Marketed |
| Feb 29, 2016 | Acyclovir SodiumANDA 205771 | Hikma | 0 | Discontinued |
| Mar 29, 2017 | Acyclovir SodiumANDA 203927 | Pharmobedient | 0 | Discontinued |
| Jun 13, 2017 | Acyclovir SodiumANDA 206606 | Zydus Pharms | 1 | Discontinued |
| Aug 31, 2018 | Acyclovir SodiumANDA 206535 | Zydus Pharms | 1 | Marketed |
| Jun 17, 2020 | Acyclovir SodiumANDA 207919 | Dr Reddys | 0 | Discontinued |
| Jan 8, 2024 | Acyclovir SodiumANDA 218111 | Hainan Poly | 0 | Marketed |
| Jun 25, 2024 | Acyclovir SodiumANDA 215404 | Fresenius Kabi USA | 0 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Glaxosmithkline
Abbvie